Chemoinformaics analysis of (2E,4E)-2,4-DODECADIENAL
Molecular Weight | 180.291 | nRot | 8 |
Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
Exact Molecular Weight | 180.151 | nRing | 0 |
Solubility: LogS | -3.11 | nHRing | 0 |
Solubility: LogP | 3.569 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 34.1779 |
nHD | 0 | BPOL | 20.9321 |
QED | 0.316 |
Synth | 2.777 |
Natural Product Likeliness | 2.195 |
NR-PPAR-gamma | 0.035 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.097 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.601 |
MDCK | 0.0000215 |
BBB | 0.996 |
PPB | 0.66367 |
VDSS | 1.688 |
FU | 0.16745 |
CYP1A2-inh | 0.648 |
CYP1A2-sub | 0.709 |
CYP2c19-inh | 0.23 |
CYP2c19-sub | 0.709 |
CYP2c9-inh | 0.099 |
CYP2c9-sub | 0.835 |
CYP2d6-inh | 0.068 |
CYP2d6-sub | 0.825 |
CYP3a4-inh | 0.15 |
CYP3a4-sub | 0.195 |
CL | 4.247 |
T12 | 0.584 |
hERG | 0.053 |
Ames | 0.845 |
ROA | 0.873 |
SkinSen | 0.986 |
Carcinogencity | 0.66 |
EI | 0.987 |
Respiratory | 0.963 |
NR-Aromatase | 0.576 |
Antiviral | No |
Prediction | 0.713924 |